Shanghai Haohai Biological Technology Co., Ltd.
SHH: 688366.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yongtai Hou
- Employees
- 2,156
- Headquarters
- Shanghai, China
- IPO year
- 2019
- Market cap
- CN¥7.4B
- Website
- https://www.3healthcare.com
Loading 688366…
Loading profile data…Frequently asked questions about 688366
What does Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) do?
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, the United States, the United Kingdom, and internationally. It offers ophthalmology products comprising intraocular lens, ophthalmic viscoelastic devices, orthokeratology and phakic refractive len...
Where does 688366.SS trade?
Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) trades on the Shanghai Stock Exchange.
What sector is 688366.SS in?
Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Shanghai Haohai Biological Technology Co., Ltd.?
Yongtai Hou is the chief executive officer of Shanghai Haohai Biological Technology Co., Ltd. (688366.SS).
Where is Shanghai Haohai Biological Technology Co., Ltd. headquartered?
Shanghai Haohai Biological Technology Co., Ltd. is headquartered in China.
Does 688366.SS pay a dividend?
Yes — Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) paid a trailing twelve-month dividend of CNY 1.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688366.SS go public?
Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) completed its initial public offering in 2019.